RTSN Insider Trading Activity and SEC Form 4 Filings
RTSN insider trading summary
Over the past 12 months, insiders at Retension Pharmaceuticals, Inc. (RTSN) reported 2 open-market purchases worth $370K by 2 insiders and no sales on SEC Form 4. Net insider buying was $370K.
Latest RTSN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Franklin M Berger | Director | Buy | $120K (10,000 @ $12.00) |
| Oct 13, 2026 | Eric L. Keller | Chief Executive Officer | Buy | $250K (20,800 @ $12.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.